DUPUYTREN LITERATURE: HEMOSIDERIN AND/OR PERIVASCULAR HEMORRHAGE

These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Selected Publications: perivascular hemorrhage or hemosiderin

Medline Title Search (Dupuytren + (“Hemosiderin” or “Perivascular hemorrhage”))

• Berg E, Marino AA, Becker RO. (1972). “Dupuytren’s Contracture: Some Associated Biophysical Abnormalities.” Clinical Orthopaedics and Related Research 83: 144–48. (PDF)
• Davis JE. (1965). “On Surgery of Dupuytren’s Contracture.” Plastic and Reconstructive Surgery 36 (3): 277–314. (PDF)
• Larsen Robert D, Takagishi Nahoto, Posch Joseph L. (1960). “The Pathogenesis of Dupuytren’s Contracture: Experimental and Further Clinical Observations Robert.” J Bone Joint Surg Am 42: 993–1007. (PDF)
• Iwasaki H, Muller H, Stutte HJ, Brennscheidt U. (1984). “Palmar Fibromatosis (Dupuytren’s Contracture). Ultrastructural and Enzyme Histochemical Studies of 43 Cases.” Virchows Arch A Pathol Anat Histopathol 405 (1): 41–53. (PDF)
• Tyrkkö J, Viljanto J. (1975). “Significance of Histopathological Findings in Dupuytren’s Contracture.” Annales Chirurgiae et Gynaecologiae Fenniae 64 (5): 288–91. (PDF)

Selected Publications: perivascular

Medline Title Search (Dupuytren + (Perivascular OR Peri-vascular)))

• Allen RA, Woolner LB, Ghormley RK. Soft-tissue tumors of the sole; with special reference to plantar fibromatosis. J Bone Joint Surg Am. 1955;37-A(1):14-26. http://www.ncbi.nlm.nih.gov/pubmed/13233265. (PDF)
• Andrew JG, Andrew SM, Ash A, Turner B. An investigation into the role of inflammatory cells in Dupuytren’s disease. J Hand Surg Br. 1991;16(3):267-271. (PDF)
• Berndt A, Kosmehl H, Mandel U, et al. TGF beta and bFGF synthesis and localization in Dupuytren’s disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J. 1995;27(12):1014-1020. (PDF)
• Chiu HF, McFarlane RM. Pathogenesis of Dupuytren’s contracture: a correlative clinical-pathological study. J Hand Surg Am. 1978;3(1):1-10. (PDF)
• Comtet JJ, Bourne-Branchu B, Herzberg G, Bertrand HG, Loire R. Lesions of digital arteries in Dupuytren’s disease. A study of twelve cases. Ann Chir Main. 1985;4(3):226-32. (PDF)
• Davis JE. On surgery of Dupuytren’s contracture. Plast Reconstr Surg. 1965;36(3):277-314. http://www.ncbi.nlm.nih.gov/pubmed/5318808. Accessed October 11, 2014. (PDF)
• Fitzgerald AM, Kirkpatrick JJ, Foo IT, Naylor IL. A picropolychrome staining technique applied to Dupuytren’s tissue. J Hand Surg Br. 1995;20(4):519-524. doi:10.1016/s0266-7681(05)80167-6 (PDF)
• Flint MH. The genesis of the palmar lesion. In: McFarlane RM, McGrouther DA, Flint MH (Eds): Dupuytren’s Disease Biology and Treatment Churchill Livingstone Edinburg 1990. ; 1990:136-154. (PDF)
• Gonzalez AM, Buscaglia M, Fox R, et al. Basic fibroblast growth factor in Dupuytren’s contracture. Am J Pathol. 1992;141(3):661-671. (PDF)
• Hueston J. Chapter 3: Pathology. In: Hueston J, ed. Dupuytren’s Contracture. London: Livingstone; 1963:22-51. (PDF)
• Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol. 1996;106(4):729-733. (PDF)
• Iwasaki H, Müller H, Stutte HJ, Brennscheidt U. Palmar fibromatosis (Dupuytren’s contracture). Ultrastructural and enzyme histochemical studies of 43 cases. Virchows Arch A Pathol Anat Histopathol. 1984;405(1):41-53. http://www.ncbi.nlm.nih.gov/pubmed/6150573. Accessed October 8, 2013. (PDF)
• Kischer CW, Speer DP. Microvascular changes in Dupuytren’s contracture. J Hand Surg Am. 1984;9a(1):58-62. (PDF)
• Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol. 1982;13(9):819-824. doi:10.1016/S0046-8177(82)80078-6 (PDF)
• Lagier R, Meinecke R. Pathology of “knuckle pads”. Study of four cases. Virchows Arch A Pathol Anat Histol. 1975;365(3):185-191. http://www.ncbi.nlm.nih.gov/pubmed/804749. (PDF)
• Larsen R. Dupuytren’s contracture. In: Flynn J, ed. Hand Surgery. Baltimore; 1966:922-952. (PDF)
• Larsen RD, Posch JL. Dupuytren’s contracture; with special reference to pathology. J Bone Joint Surg Am. 1958;40-A(4):773-92. (PDF)
• Larsen RD, Takagishi N, Posch JL. The Pathogenesis of Dupuytren’s Contracture: Experimental and Further Clinical Observations. J Bone Jt Surg Am. 1960;42(6):993-1007. (PDF)
• Lubahn JD, Pollard M, Cooney T. Immunohistochemical evidence of nerve growth factor in Dupuytren’s diseased palmar fascia . J Hand Surg Am . 2007;32(3):42-337. doi:10.1016/j.jhsa.2006.12.011 (PDF)
• Luck J V. Dupuytren’s contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am. 1959;41-A(4):635-664. (PDF)
• Maccallum P, Hueston JT. The pathology of Dupuytren’s contracture. Aust N Z J Surg. 1962;31:241-253. (PDF)
• Mackey SL, Cobb MW. Knuckle pads. Cutis. 1994;54(3):159-160. http://www.ncbi.nlm.nih.gov/pubmed/7813233. Accessed March 31, 2014. (PDF)
• Mayerl C, Del Frari B, Parson W, et al. Characterisation of the inflammatory response in Dupuytren’s disease. J Plast Surg Hand Surg. 2016;6764(February):1-9. doi:10.3109/2000656X.2016.1140054 (PDF)
• Meek RMD, McLellan S, Crossan JF, Crossan SMJF. Dupuytren’s disease. A model for the mechanism of fibrosis and its modulation by steroids. J Bone Jt Surg Br. 1999;81(4):732-738. (PDF)
• Meyerding H, Black J, Broders A. The etiology and pathology of dupuytren’s contracture. Surg Gynecol Obs. 1941;72:582-590. (PDF)
• Millesi H. On the pathogenesis and therapy of Dupuytren’s contracture (a study based on more than 500 cases). In: Bauer K, Brunner A, Lindemann K, eds. Results of Surgery and Orthopedics. Vol 47. Berlin, Heidelberg: Springer; 1965:4-101. doi:10.1007/978-3-642-94908-1_2 (PDF)
• Millesi H. The Clinical And Morphological Course Of Dupuytren’s Disease. In: Hueston J, Tubiana R, eds. Dupuytren’s Disease. Grune& Stratton, London; 1974:49-60. (PDF)
• Mohr W, Wessinghage D. Morphology of Dupuytren’s Disease. In: Dupuytren’s Disease Pathobiochemistry and Clinical Management. ; 1994:3-15. (PDF)
• Murrell GA, Francis MJ, Howlett CR. Dupuytren’s contracture. Fine structure in relation to aetiology. J Bone Joint Surg Br. 1989;71(3):367-373. http://www.ncbi.nlm.nih.gov/pubmed/2722922. Accessed October 13, 2013. (PDF)
• Murrell GACAC, Francis MJOJO, Howlett CRR. Myofibroblasts Are Not Specific to Dupuytren’s Disease. In: Dupuytren’s Disease Pathobiochemistry and Clinical Management. ; 1994:24-33. (PDF)
• On N, Koh SP, Brasch HD, Dunne JC, Armstrong JR, Tan ST, et al. Embryonic Stem Cell-Like Population in Dupuytren’s Disease Expresses Components of the Renin-Angiotensin System. Plast Reconstr Surg Glob Open. 2017;5(7):e1422. (PDF)
• Qureshi FI, Hornigold R, Spencer JD, Hall SM. Langerhans cells in Dupuytren’s contracture. J Hand Surg Br. 2001;26(4):362-367. doi:10.1054/jhsb.2000.0518 (PDF)
• Schurch W, Skalli O, Gabbiani G. Chapter 4: Cellular biology. In: Dupuytren’s Disease Biology and Treatment. ; 1990:31-47. (PDF)
• Shum DT, McFarlane RM. Histogenesis of Dupuytren’s disease: an immunohistochemical study of 30 cases. J Hand Surg Am. 1988;13(1):61-67. (PDF)
• Shum DT, Pringle G, Hasegawa B, Botz JS, McFarlane RM. Demonstration of Myofibroblasts Using a Novel Murine Monoclonal Antibody, 3C2G10.7 Raised from Proliferating Cells in Dupuytren’s Disease. In: Dupuytren’s Disease Pathobiochemistry and Clinical Management. 1994:127-138. (PDF)
• Shum DT. Chapter 3: Histopathology. In: Dupuytren’s Disease Biology and Treatment. 1990:25-30. (PDF)
• Skoog T. Chapter 3. Pathology and Pathogenesis. In: Skoog, T: Dupuytren’s Contraction With Special Reference To Aetiology And Improved Surgical Treatment Its Occurrence In Epileptics Note On Knuckle-Pads. Acta Chirurgica Scandinavica 1948;Vol 96, Suppl 139. ; 1948:38-64. (PDF)
• Skoog T. Chapter 4. Dupuytrens Contraction of the Plantar Aponeurosis. In: Skoog, T: Dupuytren’s Contraction With Special Reference To Aetiology And Improved Surgical Treatment Its Occurrence In Epileptics Note On Knuckle-Pads. Acta Chirurgica Scandinavica 1948;Vol 96, Suppl 139. ; 1948:65-85. (PDF)
• Sugden P, Andrew JG, Andrew SM, Freemont AJ. Dermal dendrocytes in Dupuytren’s disease: a link between the skin and pathogenesis? J Hand Surg Br. 1993;18(5):662-666. doi:10.1016/0266-7681(93)90030-J (PDF)
• Tyrkkö J, Viljanto J. Significance of histopathological findings in Dupuytren’s contracture. Ann Chir Gynaecol Fenn. 1975;64(5):288-291. http://www.ncbi.nlm.nih.gov/pubmed/55091. Accessed November 30, 2014. (PDF)
• Viil J, Maasalu K, Mäemets-Allas K, et al. Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren’s contracture. Arthritis Res Ther. 2015;17(1). doi:10.1186/s13075-015-0661-y (PDF)
• Warren RF. The pathology of Dupuytren’s contracture. Br J Plast Surg. 1953;6(3):224-230. (PDF)